These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27206339)

  • 1. Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer.
    Zhan Y; Lin J; Liu Y; Chen M; Chen X; Zhuang C; Liu L; Xu W; Chen Z; He A; Zhang Q; Sun X; Zhao G; Huang W
    J Exp Clin Cancer Res; 2016 May; 35(1):83. PubMed ID: 27206339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma.
    Xu Y; Tong Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Xie L
    BMC Cancer; 2017 May; 17(1):373. PubMed ID: 28545465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer.
    He A; Liu Y; Chen Z; Li J; Chen M; Liu L; Liao X; Lv Z; Zhan Y; Zhuang C; Lin J; Huang W; Mei H
    J Exp Clin Cancer Res; 2016 Aug; 35(1):125. PubMed ID: 27514530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of LncRNA PANDAR predicts a poor prognosis in gastric cancer.
    Ma P; Xu T; Huang M; Shu Y
    Biomed Pharmacother; 2016 Mar; 78():172-176. PubMed ID: 26898439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
    Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
    Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
    Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma.
    Zhan Y; Li Y; Guan B; Chen X; Chen Z; He A; He S; Gong Y; Peng D; Liu Y; Cai Z; Li X; Zhou L
    Oncotarget; 2017 Jul; 8(27):44326-44334. PubMed ID: 28574830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
    Peng W; Fan H
    Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of LncRNA PANDAR predicts poor prognosis and promotes cell proliferation in cervical cancer.
    Huang HW; Xie H; Ma X; Zhao F; Gao Y
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4529-4535. PubMed ID: 29131264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of long non-coding RNA PANDAR and its prognostic value in colorectal cancer patients.
    Li X; Wang F; Sun Y; Fan Q; Cui G
    Int J Biol Markers; 2017 May; 32(2):e218-e223. PubMed ID: 28106228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
    Li J; Zhuang C; Liu Y; Chen M; Chen Y; Chen Z; He A; Lin J; Zhan Y; Liu L; Xu W; Zhao G; Guo Y; Wu H; Cai Z; Huang W
    J Exp Clin Cancer Res; 2016 Jun; 35(1):99. PubMed ID: 27328915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of lncRNA PANDAR reduces cell proliferation, cell invasion and suppresses EMT pathway in breast cancer.
    Li Y; Su X; Pan H
    Cancer Biomark; 2019; 25(2):185-192. PubMed ID: 31104011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2.
    Zhan Y; Chen Z; He S; Gong Y; He A; Li Y; Zhang L; Zhang X; Fang D; Li X; Zhou L
    Mol Cancer; 2020 Feb; 19(1):25. PubMed ID: 32019566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA PANDAR blocks CDKN1A gene transcription by competitive interaction with p53 protein in gastric cancer.
    Liu J; Ben Q; Lu E; He X; Yang X; Ma J; Zhang W; Wang Z; Liu T; Zhang J; Wang H
    Cell Death Dis; 2018 Feb; 9(2):168. PubMed ID: 29416011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of long non-coding RNA ROR1-AS1 promotes cell growth and migration in bladder cancer by regulation of miR-504.
    Chen Q; Fu L
    PLoS One; 2020; 15(1):e0227568. PubMed ID: 31929567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
    Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W
    Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder.
    Pei L; Yan D; He Q; Kong J; Yang M; Ruan H; Lin Q; Huang L; Huang J; Lin T; Qin H
    Cell Oncol (Dordr); 2023 Oct; 46(5):1509-1527. PubMed ID: 37355516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer.
    Liao X; Chen J; Liu Y; He A; Wu J; Cheng J; Zhang X; Lv Z; Wang F; Mei H
    Cancer Biomark; 2018 Feb; 21(2):277-285. PubMed ID: 29226855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA CCAT1 promotes bladder cancer cell proliferation, migration and invasion.
    Zhang C; Wang W; Lin J; Xiao J; Tian Y
    Int Braz J Urol; 2019; 45(3):549-559. PubMed ID: 31038865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer.
    Lin J; Zhan Y; Liu Y; Chen Z; Liang J; Li W; He A; Zhou L; Mei H; Wang F; Huang W
    Oncotarget; 2017 Apr; 8(15):24202-24212. PubMed ID: 28445936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.